ANI (ANIP) Meredith Cook, Sr. VP & GC Sells 500 Shares

What Happened
Meredith Cook, Senior Vice President, General Counsel and Secretary of ANI Pharmaceuticals (ANIP), reported the sale of 500 shares on July 13, 2026. The shares were disposed at $81.84 per share for a total of $40,920. This was a sale (not a purchase), a type of transaction that is often routine for insiders.

Key Details

• Transaction date: 2026-07-13; Form 4 filed: 2026-07-14 (filed timely).
• Transaction: Sale of 500 shares at $81.84 each; total proceeds $40,920.
• Reported as an "open market or private sale" on the Form 4.
• Footnote: The sale was executed pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on September 15, 2025.
• Shares owned after the transaction: Not disclosed in the provided filing.

Context
A 10b5-1 plan is a pre-established trading plan that allows insiders to sell shares according to a schedule or formula; transactions under such plans are commonly considered routine and reduce the implication of trading based on current non-public information. Sales do not necessarily indicate negative views about the company—retail investors should view this as one data point among many when assessing insider activity.